Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG-CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis in vitro and modulate myeloma disease in vivo. Ap...

Descripció completa

Dades bibliogràfiques
Autors principals:	Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P
Format:	Journal article
Idioma:	English
Publicat:	2007

Ítems similars

Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
per: Roelofs, A, et al.
Publicat: (2005)

APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
per: Croucher, P, et al.
Publicat: (2002)

Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
per: Roelofs, A, et al.
Publicat: (2007)

Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
per: Roelofs, A, et al.
Publicat: (2006)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
per: Croucher, P, et al.
Publicat: (2003)

Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma
per: Mueller, G, et al.
Publicat: (2004)

5T2MM murine myeloma cells and CD138+ve human myeloma cells promote osteoclastic activity rather than osteoclast formation in vitro
per: Mueller, G, et al.
Publicat: (2004)

HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
per: Aronson, J, et al.
Publicat: (1990)

Pleiotropic effects of the HMG-CoA reductase inhibitors
per: Mihos CG, et al.
Publicat: (2011-04-01)

Regulation of HMG-CoA reductase activity in plants.
per: B A Stermer, et al.
Publicat: (1994-07-01)

Activation of HMG-CoA reductase by microsomal phosphatase
per: K R Feingold, et al.
Publicat: (1983-03-01)

The discovery and development of HMG-CoA reductase inhibitors.
per: A Endo
Publicat: (1992-11-01)

HMG-CoA reductase kinase: measurement of activity by methods that preclude interference by inhibitors of HMG-CoA reductase activity or by mevalonate kinase.
per: H J Harwood, Jr, et al.
Publicat: (1982-07-01)

Bisphosphonates--mechanisms of action in multiple myeloma.
per: Shipman, C, et al.
Publicat: (2000)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
per: Shipman, C, et al.
Publicat: (2000)

Osteoprotegerin and the development of myeloma bone disease
per: Croucher, P, et al.
Publicat: (2004)

HMG CoA reductase of intestinal mucosa and liver of the rat
per: S. Shefer, et al.
Publicat: (1972-05-01)

HMG-CoA reductase is not the site of the primary defect in phytosterolemia
per: G.M.B. Berger, et al.
Publicat: (1998-05-01)

Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression.
per: JJ Hwa, et al.
Publicat: (1992-05-01)

Bisphosphonates and in vivo models of multiple myeloma - Reply
per: Shipman, C, et al.
Publicat: (2001)

The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
per: Marc M Schumacher, et al.
Publicat: (2015-03-01)

Stimulatory effect of dietary lipid and cholestyramine on hepatic HMG CoA reductase
per: Stanley Goldfarb, et al.
Publicat: (1972-11-01)

QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition
per: Robert Ancuceanu, et al.
Publicat: (2024-10-01)

HMG-CoA Reductase Inhibitors from Monascus-Fermented Rice
per: Xuemei Li, et al.
Publicat: (2013-01-01)

Eupatilin Alleviates Hyperlipidemia in Mice by Inhibiting HMG-CoA Reductase
per: Kyung-Joo Kim, et al.
Publicat: (2023-01-01)

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
per: Paolo Gelosa, et al.
Publicat: (2007-11-01)

Induction of HMG CoA reductase by the administration of 20,25-diazacholesterol
per: R Langdon, et al.
Publicat: (1977-01-01)

MTD–CoMSIA modelling of HMG-CoA reductase inhibitors
per: DANIEL M. DUDA-SEIMAN, et al.
Publicat: (2011-01-01)

Measurement of human leukocyte microsomal HMG-CoA reductase activity.
per: H J Harwood, Jr, et al.
Publicat: (1984-09-01)

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
per: Jobin Jean, et al.
Publicat: (2004-05-01)

Diurnal variation of HMG CoA reductase activity in rat intestine
per: S. Shefer, et al.
Publicat: (1972-09-01)

Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
per: Noel Lorenzo Villalba, et al.
Publicat: (2021-06-01)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
per: Croucher, P, et al.
Publicat: (2001)

Mutations within the membrane domain of HMG-CoA reductase confer resistance to sterol-accelerated degradation
per: Peter C.W. Lee, et al.
Publicat: (2007-02-01)

Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
per: Gene C. Ness, et al.
Publicat: (1998-01-01)

Rapid reverse phase-HPLC assay of HMG-CoA reductase activity
per: Matteo Mozzicafreddo, et al.
Publicat: (2010-08-01)

Inactivation of rat liver HMG-CoA reductase phosphatases by polycarboxylic acids.
per: F G Hegardt, et al.
Publicat: (1983-07-01)

Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor
per: Sucharita Bose, et al.
Publicat: (2023-04-01)

Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
per: Hongwen Chen, et al.
Publicat: (2022-07-01)

Are Point Mutations in HMG-CoA Reductases (Hmg1 and Hmg2) a Step towards Azole Resistance in <i>Aspergillus fumigatus</i>?
per: Irene Gonzalez-Jimenez, et al.
Publicat: (2021-10-01)